Skip to main content
. Author manuscript; available in PMC: 2019 Apr 5.
Published in final edited form as: J Cutan Pathol. 2018 May 29;45(8):588–596. doi: 10.1111/cup.13265

TABLE A1.

Self-reported characteristics of M-Path study pathologists who completed the baseline survey (N = 187)

Physician characteristics N (%)
Demographics
 Age (years)
  <40 31 (16.6%)
  40–49 56 (29.9%)
  50–59 63 (33.7%)
  ≥60 37 (19.8%)
 Gender
  Female 73 (39.0%)
  Male 114 (61.0%)
Training and experience
 Affiliation with academic medical center
  No 134 (71.7%)
  Yes, adjunct/affiliated 34 (18.2%)
  Yes, primary appointment 19 (10.2%)
 Residency
  Anatomic/clinical pathology 168 (89.8%)
  Dermatology 15 (8.0%)
  Both dermatology and anatomic/clinical pathology 4 (2.1%)
Training
Board certified or fellowship trained in dermatopathologya 74 (39.6%)
Other board certification of fellowship trainingb 113 (60.4%)
Years interpreting melanocytic skin lesions
<5 29 (15.5%)
5–9 45 (24.1%)
10–19 57 (30.5%)
≥20 56 (29.9%)
Percent of caseload interpreting melanocytic skin lesions
<10% 79 (42.2%)
10–24% 72 (38.5%)
25–49% 28 (15.0%)
≥50% 8 (4.3%)
Average number of melanoma cases (melanoma in situ and invasive melanoma) interpreted per month
<5 82 (43.9%)
5–9 47 (25.1%)
≥10 58 (31.0%)
Average number of benign melanocytic skin lesions interpreted per month
<25 54 (28.9%)
25–49 32 (17.1%)
50–149 51 (27.3%)
≥150 50 (26.7%)
Considered an expert in melanocytic skin lesions by colleagues
No 108 (57.8%)
Yes 79 (42.2%)
Feelings/thoughts about interpreting melanocytic skin lesions
In general, how challenging do you find melanocytic skin lesions to interpret?
Challenging 179 (95.7%)
Easy 8 (4.3%)
Interpreting melanocytic skin lesions makes me more nervous that other types of pathology
Agree 129 (69.0%)
Disagree 58 (31.0%)
In general, how confident are you in your assessments of melanocytic skin lesions?
Confident 161 (86.1%)
Not confident 26 (13.9%)
a

This category consists of physicians with single or multiple fellowships that include dermatopathology. Also includes physicians with single or multiple board certifications that include dermatopathology.

b

Other includes fellowships or board certifications in surgical pathology, cytopathology, hematopathology, etc.